![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1447586
¸Þ½ÃÇÁ¶õ(Mesifurane) ½ÃÀå : À¯Çüº°, ¿ëµµº°, ÆÇ¸Å ä³Îº° & ¿¹Ãø, 2024-2032³âMesifurane Market - By Type (Natural Mesifurane, Synthetic Mesifurane); By Applications (Food Industry, Pharmaceuticals, Cosmetics & Personal Care) By Distribution Channel (Direct Sales, Wholesale, Retail Channels) & Forecast, 2024 - 2032 |
¸Þ½ÃǪ¶õ ½ÃÀå ±Ô¸ð´Â 2024³âºÎÅÍ 2032³â±îÁö ¿¬Æò±Õ 3.9% ÀÌ»ó ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ÀÚ¿¬½º·´°í ģȯ°æÀûÀÎ Á¦Ç°¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ¼±È£µµ°¡ ³ô¾ÆÁö¸é¼ Ǫ¸£Çª¶ö°ú °°Àº Àç»ý °¡´É ÀÚ¿ø¿¡¼ ÃßÃâÇÑ ¸Þ½ÃǪ¶õ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÇÕ¼º ÈÇй°ÁúÀÌ °Ç°°ú ȯ°æ¿¡ ¹ÌÄ¡´Â À¯ÇØÇÑ ¿µÇâ¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó Çâ·á ¹× ÀǾàǰ°ú °°Àº ´Ù¾çÇÑ ºÐ¾ß¿¡¼ ¹ÙÀÌ¿À ´ëüǰÀ¸·Î ÀüȯµÇ°í ÀÖ½À´Ï´Ù.
Àεµ ºê·£µå ¿¡ÄõƼ Àç´Ü(the India Brand Equity Foundation)¿¡ µû¸£¸é, Àεµ´Â ¹Ì±¹ Á¦³×¸¯ ÀǾàǰ ¼ö¿äÀÇ 40%, ¿µ±¹ Àüü ÀǾàǰÀÇ 25%¸¦ °ø±ÞÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÀǾàǰ ¼öÃâ Áõ°¡´Â ÀǾàǰ ºÎ¹®ÀÇ Á¦Ç° ¼±È£µµ¸¦ ³ôÀ̰í ÀÖ½À´Ï´Ù. ¸Þ½ÃÇÁ¶õ Á¦Á¶¸¦ À§ÇÑ »ý¸í°øÇÐ °øÁ¤ÀÇ ¹ßÀüÀ¸·Î ¸Þ½ÃÇÁ¶õÀÇ È®À强°ú ºñ¿ë È¿À²¼ºÀÌ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. À¯¸®ÇÑ Á¤ºÎ ±ÔÁ¦ÀÇ À¯ÀÔÀº ¹ÙÀÌ¿À ÈÇÐ ¹°ÁúÀÇ »ç¿ëÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. »ê¾÷°è°¡ Áö¼Ó °¡´ÉÇÑ °üÇàÀ» äÅÃÇϰí ÀÖ´Â °Íµµ ȯ°æ Ä£ÈÀû ÀÎ ´ë¾ÈÀ¸·Î ¸Þ½ÃǪ¶õ¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
¸Þ½ÃǪ¶õ ½ÃÀåÀº À¯Çü, ¿ëµµ, À¯Åë ä³Î, Áö¿ªº°·Î ºÐ·ùµË´Ï´Ù.
À¯Çüº°·Î´Â õ¿¬ ¸Þ½ÃÇÁ¶õÀ» ´ëüÇÒ ¼ö ÀÖ´Â ºñ¿ë È¿À²ÀûÀÌ°í ½±°Ô ±¸ÇÒ ¼ö ÀÖ´Â ´ëüǰ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ÇÕ¼º ¸Þ½ÃÇÁ¶õ ½ÃÀå ±Ô¸ð´Â 2024³âºÎÅÍ 2032³â±îÁö 4.1% Áõ°¡ÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. ÇÕ¼º ¸Þ½ÃÇÁ¶õÀº ǰÁú°ú ¼øµµ°¡ ¾ÈÁ¤ÀûÀ̱⠶§¹®¿¡ Çâ·á ¹× Çâ·á »ê¾÷ÀÇ ´Ù¾çÇÑ ¿ëµµ¿¡ ÀÌ»óÀûÀÎ ¼±ÅÃÀÔ´Ï´Ù. ÈÇÐ ÇÕ¼º¹ýÀÇ ¹ßÀüÀ¸·Î ÇÕ¼º ¸Þ½ÃÇÁ¶õÀÇ »ý»ê È¿À²°ú È®À强µµ Çâ»óµÇ°í ÀÖ½À´Ï´Ù.
Á¦¾à ºÐ¾ß´Â 2032³â±îÁö ¸Þ½ÃÇÁ¶õ ½ÃÀå¿¡¼ Å« ºñÁßÀ» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¿¹Ãø ±â°£ µ¿¾È 4.2%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ´Â Á¦¾à Á¦Á¦¿¡¼ õ¿¬ ¹× ¹ÙÀÌ¿À ¼ººÐ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí Àֱ⠶§¹®ÀÔ´Ï´Ù. ¸Þ½ÃÇÁ¶õÀº ÀáÀçÀûÀÎ Ä¡·á È¿°ú°¡ ÀÖÀ¸¸ç, Ç׿°Áõ ¹× Ç×±Õ ÀÛ¿ë°ú °°Àº ¾à¸®ÇÐÀû Ư¼º¿¡ ´ëÇØ Áö¼ÓÀûÀ¸·Î ¿¬±¸µÇ°í ÀÖ½À´Ï´Ù. ±×¸° Äɹ̽ºÆ®¸®¿Í Áö¼Ó °¡´ÉÇÑ Á¶´Þ¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁü¿¡ µû¶ó, ¸Þ½ÃǪ¶õÀÇ Á¦¾à ºÐ¾ß¿¡¼ÀÇ Ã¤ÅÃÀÌ ´õ¿í °¡¼Óȵǰí ÀÖ½À´Ï´Ù.
Áö¿ªº°·Î º¸¸é, ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¸Þ½ÃÇÁ¶õ ½ÃÀå ±Ô¸ð´Â 2024-2032³â »çÀÌ 4.1%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Áö¼Ó °¡´ÉÇÑ °üÇàÀÇ Ã¤Åà Áõ°¡¿Í ģȯ°æ Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡°¡ ÀÌ Áö¿ªÀÇ ¸Þ½ÃǪ¶õ ¼ö¿ä¸¦ ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¸Þ½ÃǪ¶õ Á¦Á¶¸¦ À§ÇÑ »ý¸í°øÇÐ °øÁ¤ÀÇ ¹ßÀü°ú Á¤ºÎÀÇ ¿ìÈ£ÀûÀÎ Á¤Ã¥Àº ¹ÙÀÌ¿À ÈÇй°ÁúÀÇ »ç¿ëÀ» ÃËÁøÇÏ¿© ÀÌ Áö¿ªÀÇ Á¦Ç° ¼ö¿ä¸¦ °ßÀÎÇϰí ÀÖ½À´Ï´Ù.
Mesifurane Market size is expected to grow at over 3.9% CAGR from 2024 to 2032. The increasing consumer preference for natural and eco-friendly products is driving the demand for mesifurane derived from renewable resources like furfural. The growing awareness of the harmful effects of synthetic chemicals on health and the environment is creating the shift towards bio-based alternatives in various applications, such as flavors, fragrances, and pharmaceuticals.
According to the India Brand Equity Foundation, India supplies 40% of generic medicines demand in the U.S. and 25% of all the medicines in the UK. This rise in medicine export is increasing the product preference in the pharmaceutical sector. Rising advancements in biotechnological processes for mesifurane production are enhancing its scalability and cost-effectiveness. The influx of favorable government regulations are promoting the use of bio-based chemicals. The increasing adoption of sustainable practices by industries is also driving the demand for mesifurane as a green alternative.
The mesifurane market is segregated into type, application, distribution channel, and region.
Based on type, the market value from the synthetic mesifurane segment is estimated to rise at 4.1% from 2024 to 2032, due to the increasing demand for cost-effective and readily available alternatives to natural mesifurane. Synthetic mesifurane offers consistent quality and purity, serving as an ideal option for various applications in the fragrance and flavor industries. Rising advancements in chemical synthesis methods are also improving the efficiency and scalability of synthetic mesifurane production.
The pharmaceuticals application segment is anticipated to account for sizeable share of the mesifurane market by 2032, while exhibiting 4.2% CAGR during the forecast period. This is on account of the increasing demand for natural and bio-based ingredients in pharmaceutical formulations. Mesifurane offers potential therapeutic benefits and is continuously explored for its pharmacological properties, including anti-inflammatory and antimicrobial effects. The growing focus on green chemistry and sustainable sourcing is further driving the adoption of mesifurane in pharmaceutical applications.
Regionally, the Asia Pacific mesifurane market size is projected to depict 4.1% CAGR between 2024 and 2032, owing to the expanding industrial and manufacturing sectors. The increasing adoption of sustainable practices and the growing demand for eco-friendly products are driving the demand for mesifurane in the region. The increasing advancements in biotechnological processes for mesifurane production and the influx of favorable government policies are also supporting the use of bio-based chemicals, driving the regional product demand.